
Ask a doctor about a prescription for RIVAROXABAN MACLEODS PHARMA 15 mg + 20 mg FILM-COATED TABLETS
Package Leaflet:information for the patient
Rivaroxaban Macleods 15 mg + 20 mg film-coated tablets EFG
Starter pack for treatment initiation
Not for use in children.
Read all of this leaflet carefully before you start taking this medicine,because it contains important information for you.
Contents of the pack
5 Storage of Rivaroxaban Macleods
Rivaroxaban Macleods contains the active substance rivaroxaban and is used in adults to:
Rivaroxaban Macleods belongs to a group of medicines called antithrombotic agents. It works by blocking a factor involved in blood clotting (factor Xa) and thus reducing the tendency of blood to form clots.
Do not take Rivaroxaban Macleods
Do not take Rivaroxaban Macleods and inform your doctorif any of these conditions apply to you.
Warnings and precautions
Consult your doctor or pharmacist before taking Rivaroxaban Macleods.
Be careful with Rivaroxaban Macleods
Tell your doctor if you have any of these conditionsbefore taking Rivaroxaban Macleods. Your doctor will decide if you should be treated with this medicine and if you should be closely monitored.
If you need to have surgery
Children and adolescents
The starter pack for Rivaroxaban Macleods is not recommended for persons under 18 years of age, as it is designed specifically for the initiation of treatment in adult patients and is not suitable for use in children and adolescents.
Other medicines and Rivaroxaban Macleods
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines, including those obtained without a prescription.
If any of these conditions apply to you, tell your doctorbefore taking Rivaroxaban Macleods, as the effect of Rivaroxaban Macleods may be increased. Your doctor will decide if you should be treated with this medicine and if you should be closely monitored.
If your doctor considers that you have a higher risk of developing a stomach or intestinal ulcer, they may recommend that you also use a preventive treatment.
If any of these conditions apply to you, tell your doctorbefore taking Rivaroxaban Macleods, as the effect of Rivaroxaban Macleods may be reduced. Your doctor will decide if you should be treated with this medicine and if you should be closely monitored.
Pregnancy and breastfeeding
Do not take Rivaroxaban Macleods if you are pregnant or breastfeeding. If there is a possibility that you may become pregnant, use a reliable contraceptive while taking this medicine. If you become pregnant while taking this medicine, tell your doctor immediately, who will decide how you should be treated.
Driving and using machines
Rivaroxaban Macleods may cause dizziness (common side effect) or fainting (uncommon side effect) (see section 4, "Possible side effects"). Do not drive, ride a bicycle, or use tools or machines if you are affected by these symptoms.
Rivaroxaban Macleods contains lactose and sodium
If your doctor has told you that you have an intolerance to some sugars, consult them before taking this medicine.
This medicine contains less than 1 mmol of sodium (23 mg) per tablet; this is essentially "sodium-free".
Follow exactly the administration instructions of this medicine given by your doctor. If you are unsure, consult your doctor or pharmacist again.
You must take Rivaroxaban Macleods with food.
Swallow the tablets, preferably with water.
If you have difficulty swallowing the whole tablet, consult your doctor about other ways to take it. The tablet can be crushed and mixed with water or apple sauce, immediately before taking it. Then, take food.
If necessary, your doctor may also administer the crushed Rivaroxaban Macleods tablet through a gastric tube.
What dose to take
The recommended dose is one Rivaroxaban Macleods 15 mg tablet twice a day for the first 3 weeks. For treatment after 3 weeks, the recommended dose is one Rivaroxaban Macleods 20 mg tablet once a day.
This starter pack for Rivaroxaban Macleods 15 mg and 20 mg is only for the first 4 weeks of treatment.
Once this pack is finished, treatment will continue with Rivaroxaban Macleods 20 mg once a day, as indicated by your doctor.
If you have kidney problems, your doctor may decide to reduce the dose of the treatment to one Rivaroxaban Macleods 15 mg tablet once a day after 3 weeks if the risk of bleeding is higher than the risk of having another blood clot.
When to take Rivaroxaban Macleods
Take the tablets every day, until your doctor tells you to stop.
Try to take the tablets at the same time each day to remember when to take them.
Your doctor will decide how long you should continue taking the treatment.
If you take more Rivaroxaban Macleods than you should
Call your doctor immediately if you have taken too many Rivaroxaban Macleods tablets. Taking too much Rivaroxaban Macleods increases the risk of bleeding.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 91 562 04 20, indicating the medicine and the amount taken.
If you forget to take Rivaroxaban Macleods
If you stop taking Rivaroxaban Macleods
Do not stop taking Rivaroxaban Macleods without consulting your doctor first, as Rivaroxaban Macleods treats and prevents serious conditions.
If you have any other questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, Rivaroxaban Macleods can cause adverse effects, although not all people suffer from them.
Like other similar medicines to reduce blood clot formation, Rivaroxaban Macleods can cause bleeding that can put the patient's life at risk. Excessive bleeding can cause a sudden drop in blood pressure (shock). In some cases, the bleeding may not be evident.
Inform your doctor immediately if you experience any of the following symptoms:
Your doctor may decide to keep you under closer observation or change your treatment.
The frequency of these adverse effects is very rare (up to 1 in 10,000 people).
The frequencies of severe allergic reactions are very rare (anaphylactic reactions, including anaphylactic shock; may affect up to 1 in 10,000 people) and uncommon (angioedema and allergic edema; may affect up to 1 in 100 people).
General list of possible adverse effects
Frequent(may affect up to 1 in 10 people)
Uncommon(may affect up to 1 in 100 people)
Rare(may affect up to 1 in 1,000 people)
Very rare(may affect up to 1 in 10,000 people)
Frequency not known(frequency cannot be estimated from available data)
Reporting of adverse effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that is not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiration date that appears on the packaging and on each blister after "CAD". The expiration date is the last day of the month indicated.
Store below 30°C.
Crushed tablets
Crushed tablets are stable in water or apple sauce for up to 4 hours.
Medicines should not be thrown away through wastewater or household waste. Deposit the packaging and medicines you no longer need in the SIGRE Point of the pharmacy. In case of doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. This way, you will help protect the environment.
Composition of Rivaroxaban Macleods
Tablet core: microcrystalline cellulose, lactose monohydrate, croscarmellose sodium, anhydrous colloidal silica, hypromellose, sodium lauryl sulfate, magnesium stearate.
Tablet film coating: hypromellose, macrogol, macrogol, titanium dioxide (E 171), red iron oxide (E 172).
Appearance of the product and package contents
Rivaroxaban Macleods 10 mg film-coated tablets are pink, round, biconvex, engraved with "J 8" on one side and smooth on the other.
They are packaged in blisters in packs of 10, 28, 30, and 98 film-coated tablets.
Only some pack sizes may be marketed.
Marketing authorization holder and manufacturer
Marketing authorization holder
Macleods Pharma España, S.L.U.
World Trade Center Barcelona
Moll de Barcelona, s/n,
08039 Barcelona, Spain
Manufacturer
Synoptis Industrial Sp. z o.o.
Rabowicka 15, Swarzedz,
62-020, Poland
Date of the last revision of thisleaflet:
January 2024.
Detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es/).
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for RIVAROXABAN MACLEODS PHARMA 15 mg + 20 mg FILM-COATED TABLETS – subject to medical assessment and local rules.